Home › Kanser sa Atay (Hepatocellular Carcinoma) › Washington › Seattle

Pag-aaral pangklinika para sa Kanser sa Atay (Hepatocellular Carcinoma) sa Seattle, WA

Isang pag-aaral para sa Kanser sa Atay (Hepatocellular Carcinoma) ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Seattle. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.

Opisyal na teksto ng pag-aaral (English)

Nagha-hire para sa pag-aaral dito? I-highlight ito sa tuktok ng pahinang ito — $99 sa loob ng 30 araw →

Study of the Theranostic Pair RYZ811 (Diagnostic) and RYZ801 (Therapeutic) to Identify and Treat Subjects With GPC3+ (Glypican-3) Unresectable HCC

Nagre-recruitPhase 1/2

Research Facility, Seattle

Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT06726161

Symbiotic-GI-13: A Study to Learn About Study Medicine Called PF-08634404 as a Single Treatment and Combination Treatment in Adult Participants With a Liver Cancer Called Hepatocellular Carcinoma, That is Too Advanced to be Removed by Surgery and May Have Spread to Other Parts of the Body.

Nagre-recruitPhase 1/2

Virginia Mason Medical Center, Seattle
Fred Hutchinson Cancer Center, Seattle
University of Washington Medical Center- Montlake, Seattle

Edad 18 pataas · Lahat ng kasarian · Na-update Set 28, 2026 · NCT07227012

A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants With First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC) (ROSETTA HCC-206)

Nagre-recruitPhase 1/2

Local Institution - 0083, Seattle

Edad 18 pataas · Lahat ng kasarian · Na-update Set 23, 2026 · NCT07291076

GPC3-Targeted T-Cell Therapy (ECT204) in Adults With Advanced HCC

Nagre-recruitPhase 1/2

Fred Hutchinson Cancer Center, University of Washington, Seattle

Edad 18 pataas · Lahat ng kasarian · Na-update Set 10, 2026 · NCT04864054

Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma

Nagre-recruitPhase 3

Research Site, Seattle

Edad 18 pataas · Lahat ng kasarian · Na-update Set 3, 2026 · NCT06921785

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

Nagre-recruitPhase 2

University of Washington School of Medicine, Seattle

Edad 8 pataas · Lahat ng kasarian · Na-update Hul 27, 2026 · NCT05503797

Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI

Nagre-recruit

VA Puget Sound Health Care System Seattle Division, Seattle, WA, Seattle

Edad 18 hanggang 75 · Lahat ng kasarian · Na-update Hun 17, 2026 · NCT05486572

A Study of TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular Carcinoma

Nagre-recruitPhase 1/2

Virginia Mason Medical Center, Seattle

Edad 18 pataas · Lahat ng kasarian · Na-update Abr 27, 2026 · NCT05440708

Immunotherapy for Solid Tumor Malignancies in Pediatrics Using Interleukin-15 and -21 Armored Glypican-3-specific Chimeric Antigen Receptor T Cells

Nagre-recruitPhase 1

Seattle Children's Hospital, Seattle

Edad 1 hanggang 26 · Lahat ng kasarian · Na-update Peb 17, 2026 · NCT07148050

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

Nagre-recruitObservasyonal na pag-aaral

Massive Bio SYNERGY-AI site, Seattle

Lahat ng edad · Lahat ng kasarian · Na-update Okt 28, 2025 · NCT03452774

Pag-aaral para sa Kanser sa Atay (Hepatocellular Carcinoma) sa ibang lungsod

Iba pang pag-aaral sa Seattle

Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.